| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |